Analyst Research

Report Title Price
Aurobindo Pharma Ltd (AUROPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd
Provider: Wright Reports
$460.00
Buy
Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Aurobindo Pharma falls on weak volume
Provider: News Bites Pty Limited
$5.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Aurobindo Pharma Ltd Receives USFDA Approvals For Nausea Injections-Business Standard


Monday, 24 Dec 2012 01:09am EST 

Business Standard reported that Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market for Ondansetron Injections. 

Latest Developments for Aurobindo Pharma Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Aurobindo Pharma Ltd
(ARBN.NS)
180.6
-9.5 -5.00%
6:28am EDT